The risk of resting heart rate on vascular events and mortality in vascular patients

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1410-1415

  Bemelmans, Remy H H ^a   Van Der Graaf, Yolanda ^a   Nathoe, Hendrik M ^a   Wassink, Annemarie M J ^a   Vernooij, Joris W P ^a   Spiering, Wilko ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Mortality risk; Resting heart rate; Sympathetic nerve system; Vascular disease; Vascular events

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DRUG USE; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RESTING HEART RATE; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE;

MORTALITY RISK; RESTING HEART RATE; SYMPATHETIC NERVE SYSTEM; VASCULAR DISEASE; VASCULAR EVENTS;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; REST; RISK FACTORS; VASCULAR DISEASES;

EID: 84885300445     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.043     Document Type: Article

References (29)

1. Grassi G, Arenare F, Pieruzzi F, Brambilla G, Mancia G. Sympathetic activation In cardiovascular and renal disease. J Nephrol 2009;22:190-5.
2. Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007;25:909-20.
3. Grassi G, Vailati S, Bertinieri G, et al. Heart rate as marker of sympathetic activity. J Hypertens 1998;16:1635-9.
4. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate In patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74.
5. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial Infarction, and stroke In patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol 2010;105:905-11.
6. Stettler C, Bearth A, Allemann S, et al. QTc Interval and resting heart rate as long-term predictors of mortality In type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 2007;50:186-94.
7. Okin PM, Kjeldsen SE, Julius S, et al. All-cause and cardiovascular mortality In relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. Eur Heart J 2010;31:2271-9.
8. Tverdal A, Hjellvik V, Selmer R. Heart rate and mortality fromcardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years. Eur Heart J 2008;29:2772-81.
9. Hsia J, Larson JC, Ockene JK, et al. Resting heart rate as a low tech predictor of coronary events In women: prospective cohort study. BMJ 2009;338:b219.
10. Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, Ischaemic heart disease, and sudden cardiac death In middle-aged British men. Br Heart J 1993;70:49-55.
11. Greenland P, Daviglus ML, Dyer AR, et al. Resting heart rate Is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project In Industry. Am J Epidemiol 1999;149:853-62.
12. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality In a French population: role of age, gender, and blood pressure. Hypertension 1999;33:44-52.
13. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate Is an Independent risk factor for cardiovascular disease In healthy men and women. Am Heart J 2010;159:612-9.
14. Fox K, Borer JS, Camm AJ, et al. Resting heart rate In cardiovascular disease. J Am Coll Cardiol 2007;50:823-30.
15. Reil JC, Custodis F, Swedberg K, et al. Heart rate reduction In cardiovascular disease and therapy. Clin Res Cardiol 2011;100:11-9.
16. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits In post-myocardial Infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007;28:3012-9.
17. Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes In chronic heart failure (SHiFT): a randomised placebo-controlled study. Lancet 2010;376: 875-85.
18. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTiFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:807-16.
19. Bohm M, Swedberg K, Komajda M, et al. Heart rate as a risk factor In chronic heart failure (SHiFT): the Association between heart rate and outcomes In a randomised placebo-controlled trial. Lancet 2010;376:886-94.
20. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
21. Vernooij JWP, van der Graaf Y, Visseren FLJ, Spiering W. The prevalence of obesity-related Hypertension and risk for new vascular events In patients with vascular diseases. Obesity (Silver Spring) 2012;20:2118-23.
22. Bangalore S, Messerli FH, Ou FS, et al. The Association of admission heart rate and In-hospital cardiovascular events In patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients In the CRUSADE quality Improvement Initiative. Eur Heart J 2010;31:552-60.
23. Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial Infarction. Am J Cardiol 1990;65:547-53.
24. Legeai C, Jouven X, Tafflet M, et al. Resting heart rate, mortality and future coronary heart disease In the elderly: the 3C study. Eur J Cardiovasc Prev Rehabil 2011;18: 488-97.
25. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors In outpatients with atherothrombosis. JAMA 2006;295:180-9.
26. Cooney MT, Vartiainen E, Laatikainen T, Joulevi A, Dudina A, Graham I. Simplifying cardiovascular risk estimation using resting heart rate. Eur Heart J 2010;31: 2141-7.
27. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial Hypertension: the task force for the management of arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87.
28. De Ferrari GM, Crijns HJ, Borggrefe M, et al. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 2011;32:847-55.
29. Palatini P, Thijs L, Staessen JA, et al. Predictive value of clinic and ambulatory heart rate for mortality In elderly subjects with systolic Hypertension. Arch Intern Med 2002;162:2313-21.